22 Injured as Flight From Singapore to Mumbai Hit Turbulence

October 20, 2014

Singapore, Oct 20: Twenty-two passengers and crew were injured when an Airbus A380 plane operated by Singapore Airlines (SIA) and travelling from the city-state to Mumbai hit sudden turbulence during descent, the carrier said Sunday.

There were 408 passengers and 25 crew on board.

The extent of the injuries during the turbulence aboard Flight SQ 424 on Saturday evening were not given, but SIA said all the injured were attended to by medical personnel on arrival at the Mumbai airport.

Eight passengers and 14 crew were hurt, the airline said in a statement.

Ten of the injured crew members required hospitalisation but all have been discharged, SIA said.

All eight passengers were also taken to hospital and six have been discharged, the airline added.

SIA said the plane "experienced sudden turbulence during descent".

Comments

Add new comment

Coastaldigest.com reserves the right to delete or block any comments.
Coastaldigset.com is not responsible for its readers’ comments.
Comments that are abusive, incendiary or irrelevant are strictly prohibited.
Please use a genuine email ID and provide your name to avoid reject.

AstraZeneca to withdraw Covid-19 vaccine globally as demand dips after admitting side effects

News Network

May 8,2024

AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.

The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.

"As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.

According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.

The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.

London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.

Comments